The problem: Why multi-stakeholder mobilization matters now
Over the past two decades, there’s been a cultural shift in healthcare; today’s patients expect to be partners in shaping their care and are increasingly recognized as an essential part of the medicine development and delivery lifecycle.
Guidance from health authorities makes their expectations clear for patient-experience data, as the National Health Council’s Rubric to Capture the Patient Voice states: “Patients should be involved in every step of the process, including planning and dissemination.” In other words, patients are no longer just end-users — they’re partners.
The patient community has played a key role in driving change and is now routinely engaged by pharmaceutical and biotech companies to share insights and advise on solutions. However, if patients aren’t engaged at the right points in the lifecycle, and if their perspectives aren’t fully understood, valued, and acted on by other stakeholders, their valuable perspectives and influence will be limited.
True impact comes when all groups across the health ecosystem — patients, clinicians, payers, policymakers, and pharma teams — work together as equal stakeholders to set shared goals and commit to coordinated action, ensuring patient voices are integrated to inform strategy and implementation, and ultimately improve long-term patient outcomes. That’s the foundation Lumanity’s Health Empowerment Initiatives offering is built on.
The opportunity: Introducing Health Empowerment initiatives
Health Empowerment is a flexible, scalable methodology that goes beyond traditional insight gathering or awareness building, and it is designed to solve health challenges that no single group can tackle alone. It’s built on the following two principles:
- Co‑creation: bringing together different groups (patients, providers, pharma teams, payers, caregivers, and more) to design solutions side by side
- Shared goal setting: agreeing on what success looks like for everyone involved, not just one stakeholder group
What’s transformative about this approach is that it sets stakeholders up for long‑term collaboration with trust, shared language, and a clear roadmap for action. We focus on initiatives that:
- Explore unmet needs, especially in patient communities that are small, dispersed, or historically under‑engaged
Example: Bringing together rare disease patients from multiple countries with specialist clinicians to identify gaps in diagnosis, referral, and support, and how to address those items through co‑created evidence building, education, and care pathway adaptations - Improve patient experience in diagnostic pathways, support services, and payer interactions
Example: Co‑designing shared decision-making and access resources and support initiatives, like patient ambassador programs, to reduce treatment delays - Build sustainable relationships among disparate stakeholder groups
Example: Creating an ongoing multi-stakeholder working group to co-create educational campaigns that reflect real‑world needs
The track record: Programs we’ve already delivered
We’ve already applied the Health Empowerment principles in multiple successful programs. The following is one example.
The challenge: Our client, a midsize pharma company, launched the first treatment proven to change the course of a long‑neglected and misunderstood disease. Despite this breakthrough, many patients continued to experience sub-optimal care due to:
- Very few true disease experts and an emerging patient community
- A diagnosis process seen as long, complex, and uncertain
- Limited understanding among non-expert providers of the disease’s severity and the value of treating its root cause
Our approach: Lumanity supported the creation of an annual, multi‑stakeholder event bringing together patient advocacy group (PAG) representatives, patient opinion leaders (POLs), and healthcare providers from multiple specialties. This inclusive forum fostered trust, encouraged open discussion, and built connections across the fragmented community.
Impact: The event evolved into a collaborative platform for problem‑solving and setting shared priorities. This initiative has led to concrete outcomes, including informing long‑term communication campaigns, educational programs, and patient support materials, all shaped by the collective input of the community.
The invitation: How to get involved
This year, we’re building out our Health Empowerment programming, and we want to co-create it with you. We’re inviting patients, clinicians, and pharma leaders to help us answer questions like:
- How do we make multi-stakeholder mobilization sustainable over time?
- What does “shared success” look like in rare, niche, or complex therapy areas?
- How can we measure both impact and trust?
- What tools or programs can turn understanding into action faster?
We’re looking for:
- Pharma and biotech leaders who want to build trust in and impact complex markets
- Patient advocates who want their voices to drive real change
- Clinicians and care teams who want to align care delivery with patient priorities
The insights we gather will be published in an upcoming whitepaper, shared with the industry, and used to shape real projects that improve patient outcomes.
Reach out to Rachel Pryzby or contact us to find out more and register your interest in collaborating.
Your insights could impact the future of patient engagement.
